16,16 Dimethyl PGE2,
16,16 Dimethylprostaglandin E2,
16,16-Dimethyl-PGE2,
16,16-Dimethylprostaglandin E2,
E2, 16,16-Dimethylprostaglandin,
16,16-Dimethyl-pge2,
16,16-dimethylprostaglandin E2,
16,16-Dimethyl-prostaglandin E2,
dmpge2,
UNII-M790V82VAC,
16,16-dimethyl prostaglandin E2,
16,16-dimethyl PGE2,
M790V82VAC,
QAOBBBBDJSWHMU-WMBBNPMCSA-N,
39746-25-3,
9-oxo-11R,15R-dihydroxy-16,16-dimethyl-5Z,13E-prostadienoic acid,
BRN 2896843,
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4,4-dimethyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid,
DiPGE2,
(5Z,11-alpha,13E,15R)-11,15-Dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid,
5-Heptenoic acid, 7-(2-(4,4-dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-,
7-(2-(4,4-Dimethyl-3-hydroxy-1-octenyl)-3-hydroxy-5-oxocyclopentyl)-5-heptenoic acid,
FT1050,
dm-PGE2,
dmPGE(2),
AC1NR1G7,
BSPBio_001365,
SCHEMBL674246,
BML1-G03,
GTPL1926,
16,16-Dimethylrostaglandin E2,
CHEMBL1221529,
CHEBI:141046,
Prosta-5,13-dien-1-oicacid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11a,13E,15R)-,
HMS1361E07,
HMS1791E07,
HMS1989E07,
HMS3402E07,
HMS3648J05,
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11-alpha,13E,15R)-,
LMFA03010065,
ZINC13815362,
AKOS024457938,
FT-1050,
IDI1_033835,
NCGC00161290-01,
NCGC00161290-02,
NCGC00161290-03,
SR-01000946434,
SR-01000946434-1,
BRD-K92301463-001-01-4,
BRD-K92301463-001-05-5,
16,16-Dimethylprostaglandin E2, methyl acetate solution,
(5Z,11?,13E,15R)-11,15-Dihydroxy-16,16-dimethyl-9-oxo-prosta-5,13-dien-1oic acid,
(5Z,11alpha,13E,15R)-11,15-dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid,
9-Oxo-11.alpha.,15R-dihydroxy-16,16-dimethyl-prosta-5Z,13E-dien-1-oic acid,
D0U7WF,
16,16 Dimethyl PGE2,
16,16 Dimethylprostaglandin E2,
FA(22:2(OH2,Ke,cyclo)),
E2, 16,16-Dimethylprostaglandin,
C22-H36-O5,
CID5283066,
D015064,
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11alpha,13E,15R)-,